Progressive Bulbar Palsy

Complex MONDO:0008890 Pathograph 3 Show in embeddings browser Motor Neuron Disease Neurodegenerative Disease

Progressive bulbar palsy (PBP) is a motor neuron disease characterized by progressive degeneration of the bulbar (lower brainstem) motor nuclei supplying the cranial nerves IX-XII, producing a combination of lower-motor-neuron bulbar features (tongue wasting, fasciculations, flaccid dysarthria, dysphagia, dysphonia) and upper-motor-neuron (corticobulbar / pseudobulbar) features such as a brisk jaw jerk, spastic dysarthria, and emotional lability. PBP is considered a regional, bulbar-onset variant within the amyotrophic lateral sclerosis (ALS) spectrum and shares its underlying TDP-43 proteinopathy; the great majority of patients eventually develop more generalized ALS. Bulbar involvement carries a high risk of aspiration, secretion-management problems, and early respiratory compromise, and bulbar-onset disease is associated with shorter survival. Key differential diagnoses include myasthenia gravis (fatigable bulbar weakness) and brainstem stroke.

Ask OpenScientist

Ask a research question about Progressive Bulbar Palsy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

5
Pathophys.
7
Phenotypes
3
Pathograph
5
Medical Actions
3
Differentials
1
References
⚙

Pathophysiology

5
Bulbar Lower Motor Neuron Degeneration
Progressive degeneration of the lower motor neurons in the bulbar motor nuclei of the medulla (notably the hypoglossal nucleus supplying the tongue, and the nucleus ambiguus supplying pharyngeal and laryngeal muscles) denervates the muscles of speech and swallowing. This produces tongue wasting and fasciculations, flaccid dysarthria, dysphagia, and dysphonia. Electromyographic involvement of the genioglossus is a marker of bulbar lower-motor-neuron dysfunction and predicts progression to severe dysphagia and dysarthria.
lower motor neuron CL:0008039
motor neuron apoptotic process GO:0097049 ↑ INCREASED
hypoglossal nucleus UBERON:0002871
Downstream
Aspiration and Respiratory Compromise Bulbar weakness impairs swallowing and airway protection, leading to aspiration and impaired secretion clearance.
Show evidence (2 references)
PMID:34454268 SUPPORT Human Clinical
"genioglossus involvement was associated with a shorter survival (p = 0.002), a shorter time to moderate dysphagia (p = 0.0001) and to severe dysarthria"
EMG genioglossus (tongue) involvement, a marker of bulbar lower-motor-neuron degeneration, predicts dysphagia and dysarthria, the hallmark bulbar LMN deficits of PBP.
PMID:41518742 SUPPORT Human Clinical
"Lower motor neuron (LMN) signs predominated in the early phases of the disease."
In facial/bulbar-onset motor neuron disease, lower-motor-neuron signs predominate early, consistent with the bulbar LMN degeneration that defines PBP.
Corticobulbar (Upper Motor Neuron) Involvement and Pseudobulbar Affect
Degeneration of upper motor neurons projecting through the corticobulbar tracts to the bulbar nuclei produces upper-motor-neuron bulbar signs: spastic dysarthria, a brisk jaw jerk and exaggerated gag, and pseudobulbar affect (pathological laughter and crying, or emotional lability) reflecting loss of cortical control over brainstem affective motor circuits. The combination of upper- and lower-motor-neuron bulbar signs distinguishes PBP from purely lower-motor-neuron bulbar syndromes.
upper motor neuron CL:0008048
Show evidence (1 reference)
PMID:37647907 SUPPORT Human Clinical
"27.4% (N = 1070), ranging from 11.4% to 71%. Bulbar onset is a risk factor but"
A consensus review reports pseudobulbar affect (pathological laughter and crying) in ~27% of ALS-spectrum patients, with bulbar onset as a risk factor, supporting corticobulbar/pseudobulbar involvement in bulbar-predominant disease.
TDP-43 Proteinopathy
Like ALS, progressive bulbar palsy is associated with TDP-43 proteinopathy: cytoplasmic mislocalization and aggregation of TAR DNA-binding protein 43 (TDP-43) forming neuronal cytoplasmic inclusions (skein-like and globular) in degenerating motor neurons of the brainstem and anterior horn. Both nuclear loss-of-function and cytoplasmic gain-of-function consequences of TDP-43 mislocalization drive motor neuron injury.
motor neuron CL:0000100
inclusion body assembly GO:0070841 ↑ INCREASED
Show evidence (1 reference)
PMID:32799899 SUPPORT Other
"Research has focused on the formation and consequences of cytosolic protein aggregates as drivers of ALS pathology through both gain- and loss-of-function mechanisms"
Review of TDP-43 biology frames cytosolic TDP-43 aggregates as drivers of ALS-spectrum pathology through gain- and loss-of-function mechanisms.
Bulbar-Onset Variant Within the ALS Spectrum
Progressive bulbar palsy is regarded as a regional, bulbar-onset variant of motor neuron disease whose underlying pathological process is largely identical to amyotrophic lateral sclerosis, differing chiefly in the anatomical site initially affected. Disease typically spreads from the bulbar region to contiguous body regions, and most patients progress to generalized ALS with combined upper and lower motor neuron involvement.
motor neuron CL:0000100
Downstream
Bulbar Lower Motor Neuron Degeneration Bulbar-region onset spreads to involve additional motor neuron pools, evolving toward generalized ALS.
Show evidence (1 reference)
PMID:40364643 SUPPORT Other
"The main types include amyotrophic lateral sclerosis, progressive muscular atrophy, primary lateral sclerosis, and progressive bulbar palsy, the pathological processes of which are largely identical, with the main disparity lying in the location of the lesions"
A motor neuron disease review classifies progressive bulbar palsy among the main MND types whose pathological processes are largely identical to ALS, with ALS as the representative condition and the others as its variants.
Aspiration and Respiratory Compromise
Bulbar muscle weakness impairs swallowing, cough, and airway protection. Combined dysphagia and weak cough lead to retained secretions, aspiration, and recurrent respiratory tract infections, and bulbar-predominant disease compromises secretion clearance and airway management, contributing to the shorter survival seen in bulbar-onset disease.
lower motor neuron CL:0008039
Show evidence (2 references)
PMID:37816542 SUPPORT Human Clinical
"the presence of bulbar muscle predominant weakness results in deleterious effects on"
Bulbar-predominant muscle weakness has deleterious effects on airway clearance and secretion management, the mechanism underlying aspiration and respiratory risk in PBP.
PMID:41100402 SUPPORT Human Clinical
"predictors associated with shorter survival were bulbar-onset"
In a large ALS cohort, bulbar-onset disease independently predicted shorter survival, reflecting the high aspiration/respiratory burden of bulbar involvement.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Progressive Bulbar Palsy Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

7
Digestive 1
Dysphagia Dysphagia HP:0002015
Course: PROGRESSIVE
Show evidence (1 reference)
PMID:34454268 SUPPORT Human Clinical
"shorter time to moderate dysphagia (p = 0.0001) and to severe dysarthria"
Bulbar motor neuron degeneration produces progressive dysphagia.
Head and Neck 1
Drooling / Sialorrhea Drooling HP:0002307
Show evidence (1 reference)
PMID:37816542 SUPPORT Human Clinical
"Salivary secretion management includes the use of anticholinergics, botulinum toxin, and radiation therapy"
Sialorrhea from bulbar dysfunction requires salivary secretion management with anticholinergics, botulinum toxin, or radiation therapy.
Nervous System 1
Dysarthria Dysarthria HP:0001260
Course: PROGRESSIVE
Show evidence (1 reference)
PMID:34454268 SUPPORT Human Clinical
"shorter time to moderate dysphagia (p = 0.0001) and to severe dysarthria"
Bulbar lower-motor-neuron involvement produces progressive dysarthria.
Other 4
Tongue Atrophy Tongue atrophy HP:0012473
Show evidence (1 reference)
PMID:2304745 SUPPORT Human Clinical
"atrophy and fasciculations of the musculature of the tongue, dysarthria"
A progressive bulbar palsy case report describes degeneration of the medullary motor nuclei producing tongue atrophy and fasciculations, directly documenting hypoglossal lower-motor-neuron tongue wasting in PBP.
Tongue Fasciculations Tongue fasciculations HP:0001308
Show evidence (1 reference)
PMID:2304745 SUPPORT Human Clinical
"atrophy and fasciculations of the musculature of the tongue, dysarthria"
A progressive bulbar palsy case report directly documents fasciculations of the tongue musculature from hypoglossal lower-motor-neuron involvement.
Pseudobulbar Affect (Emotional Lability) Pseudobulbar affect HP:0002193
Show evidence (1 reference)
PMID:37647907 SUPPORT Human Clinical
"The prevalence of pseudobulbar affect/pathological laughter and"
Pseudobulbar affect (pathological laughter and crying / emotional lability) is a common manifestation in bulbar-spectrum motor neuron disease.
Dysphonia Dysphonia HP:0001618
💊

Medical Actions

5
Riluzole
Action: Pharmacotherapy NCIT:C15986
Disease-modifying glutamate-modulating agent approved to slow progression across the ALS/motor neuron disease spectrum, including bulbar-onset disease.
Show evidence (1 reference)
PMID:40364643 SUPPORT Other
"lateral sclerosis: riluzole, edaravone, AMX0035, and tofersen"
Riluzole is among the FDA-approved drugs that delay progression of ALS-spectrum motor neuron disease, which includes progressive bulbar palsy.
Percutaneous Endoscopic Gastrostomy (PEG)
Action: surgical procedure Ontology label: Surgical Procedure NCIT:C15329
Enteral feeding tube placed to maintain nutrition and reduce aspiration risk when bulbar dysphagia compromises safe oral intake.
Show evidence (1 reference)
PMID:41100402 SUPPORT Human Clinical
"percutaneous endoscopic gastrostomy (PEG)"
Percutaneous endoscopic gastrostomy is a standard supportive intervention in the motor neuron disease care pathway for bulbar dysphagia.
Noninvasive Ventilation (NIV)
Action: supportive care Ontology label: Supportive Care NCIT:C15747
Respiratory support for declining respiratory function and secretion-related compromise associated with bulbar and respiratory muscle weakness.
Show evidence (1 reference)
PMID:41100402 SUPPORT Human Clinical
"noninvasive ventilation (NIV)"
Noninvasive ventilation is part of the supportive management pathway in motor neuron disease, relevant to the respiratory compromise of bulbar disease.
Sialorrhea Management
Action: supportive care Ontology label: Supportive Care NCIT:C15747
Management of excess saliva with anticholinergics, salivary-gland botulinum toxin injection, or salivary-gland radiation therapy.
Show evidence (1 reference)
PMID:37816542 SUPPORT Human Clinical
"Salivary secretion management includes the use of anticholinergics, botulinum toxin, and radiation therapy"
Sialorrhea in bulbar disease is managed with anticholinergics, botulinum toxin, and radiation therapy.
Dextromethorphan/Quinidine for Pseudobulbar Affect
Action: Pharmacotherapy NCIT:C15986
Combination therapy used to treat pseudobulbar affect (pathological laughter and crying) in ALS-spectrum disease.
Show evidence (1 reference)
PMID:37647907 SUPPORT Human Clinical
"a combination of dextromethorphan and quinidine"
Dextromethorphan-quinidine combination is a recognized therapeutic option for pseudobulbar affect in the ALS/MND spectrum.
🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Progressive Bulbar Palsy:

Myasthenia Gravis MONDO:0009688
Overlapping Features Autoimmune neuromuscular junction disorder that can present with bulbar weakness, but characteristically fatigable, fluctuating, and with ocular involvement (ptosis, diplopia); responsive to acetylcholinesterase inhibitors and immunotherapy.
Distinguishing Features
  • Fatigable, fluctuating weakness rather than steadily progressive degeneration.
  • Acetylcholine receptor / MuSK antibodies and decremental response on repetitive nerve stimulation.
  • No tongue fasciculations or atrophy; no upper-motor-neuron (pseudobulbar) signs.
Show evidence (1 reference)
PMID:41194820 SUPPORT Human Clinical
"Myasthenia gravis (MG) is an autoimmune neuromuscular disorder commonly"
Myasthenia gravis is an autoimmune neuromuscular-junction disorder with fatigable weakness, distinguishing it from the degenerative bulbar palsy of PBP.
Amyotrophic Lateral Sclerosis MONDO:0004976
Overlapping Features The broader motor neuron disease into which most PBP cases evolve; ALS adds prominent limb and respiratory (spinal) motor involvement beyond the bulbar region.
Distinguishing Features
  • Generalized limb upper- and lower-motor-neuron involvement, not confined to bulbar region.
  • PBP is regarded as a bulbar-onset regional variant of the same disease process.
Show evidence (1 reference)
PMID:40364643 SUPPORT Other
"The main types include amyotrophic lateral sclerosis, progressive muscular atrophy, primary lateral sclerosis, and progressive bulbar palsy, the pathological processes of which are largely identical, with the main disparity lying in the location of the lesions"
ALS and progressive bulbar palsy are listed among the main motor neuron disease types with largely identical pathology, differing in lesion location.
Brainstem Stroke Not Yet Curated MONDO:0006686
Overlapping Features Acute vascular brainstem lesion can produce bulbar weakness (dysarthria, dysphagia) but with sudden onset, additional crossed sensory/long-tract signs, and characteristic MRI findings, contrasting with the insidious, purely motor course of PBP.
Distinguishing Features
  • Acute/sudden onset rather than insidious progression.
  • Associated long-tract and sensory signs; diffusion-restricted lesion on MRI.
{ }

Source YAML

click to show 
name: Progressive Bulbar Palsy
creation_date: "2026-06-26T00:00:00Z"
category: Complex
description: >
  Progressive bulbar palsy (PBP) is a motor neuron disease characterized by progressive
  degeneration of the bulbar (lower brainstem) motor nuclei supplying the cranial nerves
  IX-XII, producing a combination of lower-motor-neuron bulbar features (tongue wasting,
  fasciculations, flaccid dysarthria, dysphagia, dysphonia) and upper-motor-neuron
  (corticobulbar / pseudobulbar) features such as a brisk jaw jerk, spastic dysarthria,
  and emotional lability. PBP is considered a regional, bulbar-onset variant within the
  amyotrophic lateral sclerosis (ALS) spectrum and shares its underlying TDP-43
  proteinopathy; the great majority of patients eventually develop more generalized ALS.
  Bulbar involvement carries a high risk of aspiration, secretion-management problems, and
  early respiratory compromise, and bulbar-onset disease is associated with shorter
  survival. Key differential diagnoses include myasthenia gravis (fatigable bulbar
  weakness) and brainstem stroke.
disease_term:
  preferred_term: progressive bulbar palsy
  term:
    id: MONDO:0008890
    label: progressive bulbar palsy
parents:
- Motor Neuron Disease
- Neurodegenerative Disease
pathophysiology:
- name: Bulbar Lower Motor Neuron Degeneration
  description: >
    Progressive degeneration of the lower motor neurons in the bulbar motor nuclei of the
    medulla (notably the hypoglossal nucleus supplying the tongue, and the nucleus ambiguus
    supplying pharyngeal and laryngeal muscles) denervates the muscles of speech and
    swallowing. This produces tongue wasting and fasciculations, flaccid dysarthria,
    dysphagia, and dysphonia. Electromyographic involvement of the genioglossus is a marker
    of bulbar lower-motor-neuron dysfunction and predicts progression to severe dysphagia
    and dysarthria.
  cell_types:
  - preferred_term: lower motor neuron
    term:
      id: CL:0008039
      label: lower motor neuron
  locations:
  - preferred_term: hypoglossal nucleus
    term:
      id: UBERON:0002871
      label: hypoglossal nucleus
  biological_processes:
  - preferred_term: motor neuron apoptotic process
    term:
      id: GO:0097049
      label: motor neuron apoptotic process
    modifier: INCREASED
  downstream:
  - target: Aspiration and Respiratory Compromise
    description: Bulbar weakness impairs swallowing and airway protection, leading to aspiration and impaired secretion clearance.
  evidence:
  - reference: PMID:34454268
    reference_title: "Prognostic value of EMG genioglossus involvement in amyotrophic lateral sclerosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "genioglossus involvement was associated with a shorter survival (p = 0.002), a shorter time to moderate dysphagia (p = 0.0001) and to severe dysarthria"
    explanation: >
      EMG genioglossus (tongue) involvement, a marker of bulbar lower-motor-neuron
      degeneration, predicts dysphagia and dysarthria, the hallmark bulbar LMN deficits of PBP.
  - reference: PMID:41518742
    reference_title: "Facial-onset SOD1 amyotrophic lateral sclerosis: A case report and systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Lower motor neuron (LMN) signs predominated in the early phases of the disease."
    explanation: >
      In facial/bulbar-onset motor neuron disease, lower-motor-neuron signs predominate
      early, consistent with the bulbar LMN degeneration that defines PBP.
- name: Corticobulbar (Upper Motor Neuron) Involvement and Pseudobulbar Affect
  description: >
    Degeneration of upper motor neurons projecting through the corticobulbar tracts to the
    bulbar nuclei produces upper-motor-neuron bulbar signs: spastic dysarthria, a brisk jaw
    jerk and exaggerated gag, and pseudobulbar affect (pathological laughter and crying, or
    emotional lability) reflecting loss of cortical control over brainstem affective motor
    circuits. The combination of upper- and lower-motor-neuron bulbar signs distinguishes
    PBP from purely lower-motor-neuron bulbar syndromes.
  cell_types:
  - preferred_term: upper motor neuron
    term:
      id: CL:0008048
      label: upper motor neuron
  evidence:
  - reference: PMID:37647907
    reference_title: "Definitions, phenomenology, diagnosis, and management of the disorders of laughter and crying in amyotrophic lateral sclerosis (ALS): Consensus from ALS and Motor Neuron Disease Scientific Department of the Brazilian Academy of Neurology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "27.4% (N = 1070), ranging from 11.4% to 71%. Bulbar onset is a risk factor but"
    explanation: >
      A consensus review reports pseudobulbar affect (pathological laughter and crying) in
      ~27% of ALS-spectrum patients, with bulbar onset as a risk factor, supporting
      corticobulbar/pseudobulbar involvement in bulbar-predominant disease.
- name: TDP-43 Proteinopathy
  description: >
    Like ALS, progressive bulbar palsy is associated with TDP-43 proteinopathy: cytoplasmic
    mislocalization and aggregation of TAR DNA-binding protein 43 (TDP-43) forming neuronal
    cytoplasmic inclusions (skein-like and globular) in degenerating motor neurons of the
    brainstem and anterior horn. Both nuclear loss-of-function and cytoplasmic
    gain-of-function consequences of TDP-43 mislocalization drive motor neuron injury.
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  biological_processes:
  - preferred_term: inclusion body assembly
    term:
      id: GO:0070841
      label: inclusion body assembly
    modifier: INCREASED
  evidence:
  - reference: PMID:32799899
    reference_title: "The role of TDP-43 mislocalization in amyotrophic lateral sclerosis."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Research has focused on the formation and consequences of cytosolic protein aggregates as drivers of ALS pathology through both gain- and loss-of-function mechanisms"
    explanation: >
      Review of TDP-43 biology frames cytosolic TDP-43 aggregates as drivers of
      ALS-spectrum pathology through gain- and loss-of-function mechanisms.
- name: Bulbar-Onset Variant Within the ALS Spectrum
  description: >
    Progressive bulbar palsy is regarded as a regional, bulbar-onset variant of motor neuron
    disease whose underlying pathological process is largely identical to amyotrophic lateral
    sclerosis, differing chiefly in the anatomical site initially affected. Disease typically
    spreads from the bulbar region to contiguous body regions, and most patients progress to
    generalized ALS with combined upper and lower motor neuron involvement.
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  downstream:
  - target: Bulbar Lower Motor Neuron Degeneration
    description: Bulbar-region onset spreads to involve additional motor neuron pools, evolving toward generalized ALS.
  evidence:
  - reference: PMID:40364643
    reference_title: "Latest progress and challenges in drug development for degenerative motor neuron diseases."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The main types include amyotrophic lateral sclerosis, progressive muscular atrophy, primary lateral sclerosis, and progressive bulbar palsy, the pathological processes of which are largely identical, with the main disparity lying in the location of the lesions"
    explanation: >
      A motor neuron disease review classifies progressive bulbar palsy among the main
      MND types whose pathological processes are largely identical to ALS, with ALS as the
      representative condition and the others as its variants.
- name: Aspiration and Respiratory Compromise
  description: >
    Bulbar muscle weakness impairs swallowing, cough, and airway protection. Combined
    dysphagia and weak cough lead to retained secretions, aspiration, and recurrent
    respiratory tract infections, and bulbar-predominant disease compromises secretion
    clearance and airway management, contributing to the shorter survival seen in
    bulbar-onset disease.
  cell_types:
  - preferred_term: lower motor neuron
    term:
      id: CL:0008039
      label: lower motor neuron
  evidence:
  - reference: PMID:37816542
    reference_title: "Airway Clearance Strategies and Secretion Management in Amyotrophic Lateral Sclerosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the presence of bulbar muscle predominant weakness results in deleterious effects on"
    explanation: >
      Bulbar-predominant muscle weakness has deleterious effects on airway clearance and
      secretion management, the mechanism underlying aspiration and respiratory risk in PBP.
  - reference: PMID:41100402
    reference_title: "Predictors in late-stage amyotrophic lateral sclerosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "predictors associated with shorter survival were bulbar-onset"
    explanation: >
      In a large ALS cohort, bulbar-onset disease independently predicted shorter survival,
      reflecting the high aspiration/respiratory burden of bulbar involvement.
phenotypes:
- name: Dysarthria
  category: Neurologic
  description: Slurred or impaired speech from bulbar muscle weakness (flaccid and/or spastic dysarthria).
  phenotype_term:
    preferred_term: Dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:34454268
    reference_title: "Prognostic value of EMG genioglossus involvement in amyotrophic lateral sclerosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "shorter time to moderate dysphagia (p = 0.0001) and to severe dysarthria"
    explanation: Bulbar lower-motor-neuron involvement produces progressive dysarthria.
- name: Dysphagia
  category: Neurologic
  description: Progressive difficulty swallowing due to weakness of pharyngeal and tongue musculature, with aspiration risk.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:34454268
    reference_title: "Prognostic value of EMG genioglossus involvement in amyotrophic lateral sclerosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "shorter time to moderate dysphagia (p = 0.0001) and to severe dysarthria"
    explanation: Bulbar motor neuron degeneration produces progressive dysphagia.
- name: Tongue Atrophy
  category: Neurologic
  description: Wasting of the tongue musculature from hypoglossal lower-motor-neuron degeneration.
  phenotype_term:
    preferred_term: Tongue atrophy
    term:
      id: HP:0012473
      label: Tongue atrophy
  evidence:
  - reference: PMID:2304745
    reference_title: "Progressive bulbar palsy: a case report of a type of motor neuron disease presenting with oral symptoms."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "atrophy and fasciculations of the musculature of the tongue, dysarthria"
    explanation: A progressive bulbar palsy case report describes degeneration of the medullary motor nuclei producing tongue atrophy and fasciculations, directly documenting hypoglossal lower-motor-neuron tongue wasting in PBP.
- name: Tongue Fasciculations
  category: Neurologic
  description: Visible spontaneous twitching of tongue muscle bundles, a hallmark of bulbar lower-motor-neuron disease.
  phenotype_term:
    preferred_term: Tongue fasciculations
    term:
      id: HP:0001308
      label: Tongue fasciculations
  evidence:
  - reference: PMID:2304745
    reference_title: "Progressive bulbar palsy: a case report of a type of motor neuron disease presenting with oral symptoms."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "atrophy and fasciculations of the musculature of the tongue, dysarthria"
    explanation: >
      A progressive bulbar palsy case report directly documents fasciculations of the tongue
      musculature from hypoglossal lower-motor-neuron involvement.
- name: Drooling / Sialorrhea
  category: Neurologic
  description: Excess pooling of saliva and drooling due to impaired swallowing and bulbar weakness.
  phenotype_term:
    preferred_term: Drooling
    term:
      id: HP:0002307
      label: Drooling
  evidence:
  - reference: PMID:37816542
    reference_title: "Airway Clearance Strategies and Secretion Management in Amyotrophic Lateral Sclerosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Salivary secretion management includes the use of anticholinergics, botulinum toxin, and radiation therapy"
    explanation: >
      Sialorrhea from bulbar dysfunction requires salivary secretion management with
      anticholinergics, botulinum toxin, or radiation therapy.
- name: Pseudobulbar Affect (Emotional Lability)
  category: Neuropsychiatric
  description: Involuntary, exaggerated episodes of laughing or crying disproportionate to mood, from corticobulbar involvement.
  phenotype_term:
    preferred_term: Pseudobulbar affect
    term:
      id: HP:0002193
      label: Pseudobulbar affect
  evidence:
  - reference: PMID:37647907
    reference_title: "Definitions, phenomenology, diagnosis, and management of the disorders of laughter and crying in amyotrophic lateral sclerosis (ALS): Consensus from ALS and Motor Neuron Disease Scientific Department of the Brazilian Academy of Neurology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The prevalence of pseudobulbar affect/pathological laughter and"
    explanation: >
      Pseudobulbar affect (pathological laughter and crying / emotional lability) is a
      common manifestation in bulbar-spectrum motor neuron disease.
- name: Dysphonia
  category: Neurologic
  description: >-
    Impaired voice quality from laryngeal muscle weakness (nucleus ambiguus
    involvement). Recorded as a well-described clinical observation; the
    available bulbar-MND references document dysarthria and dysphagia rather
    than dysphonia specifically, so no formal evidence item is asserted here.
  phenotype_term:
    preferred_term: Dysphonia
    term:
      id: HP:0001618
      label: Dysphonia
treatments:
- name: Riluzole
  description: >
    Disease-modifying glutamate-modulating agent approved to slow progression across the
    ALS/motor neuron disease spectrum, including bulbar-onset disease.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  evidence:
  - reference: PMID:40364643
    reference_title: "Latest progress and challenges in drug development for degenerative motor neuron diseases."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "lateral sclerosis: riluzole, edaravone, AMX0035, and tofersen"
    explanation: >
      Riluzole is among the FDA-approved drugs that delay progression of ALS-spectrum motor
      neuron disease, which includes progressive bulbar palsy.
- name: Percutaneous Endoscopic Gastrostomy (PEG)
  description: >
    Enteral feeding tube placed to maintain nutrition and reduce aspiration risk when bulbar
    dysphagia compromises safe oral intake.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  evidence:
  - reference: PMID:41100402
    reference_title: "Predictors in late-stage amyotrophic lateral sclerosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "percutaneous endoscopic gastrostomy (PEG)"
    explanation: >
      Percutaneous endoscopic gastrostomy is a standard supportive intervention in the
      motor neuron disease care pathway for bulbar dysphagia.
- name: Noninvasive Ventilation (NIV)
  description: >
    Respiratory support for declining respiratory function and secretion-related compromise
    associated with bulbar and respiratory muscle weakness.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:41100402
    reference_title: "Predictors in late-stage amyotrophic lateral sclerosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "noninvasive ventilation (NIV)"
    explanation: >
      Noninvasive ventilation is part of the supportive management pathway in motor neuron
      disease, relevant to the respiratory compromise of bulbar disease.
- name: Sialorrhea Management
  description: >
    Management of excess saliva with anticholinergics, salivary-gland botulinum toxin
    injection, or salivary-gland radiation therapy.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:37816542
    reference_title: "Airway Clearance Strategies and Secretion Management in Amyotrophic Lateral Sclerosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Salivary secretion management includes the use of anticholinergics, botulinum toxin, and radiation therapy"
    explanation: >
      Sialorrhea in bulbar disease is managed with anticholinergics, botulinum toxin, and
      radiation therapy.
- name: Dextromethorphan/Quinidine for Pseudobulbar Affect
  description: >
    Combination therapy used to treat pseudobulbar affect (pathological laughter and crying)
    in ALS-spectrum disease.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  evidence:
  - reference: PMID:37647907
    reference_title: "Definitions, phenomenology, diagnosis, and management of the disorders of laughter and crying in amyotrophic lateral sclerosis (ALS): Consensus from ALS and Motor Neuron Disease Scientific Department of the Brazilian Academy of Neurology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a combination of dextromethorphan and quinidine"
    explanation: >
      Dextromethorphan-quinidine combination is a recognized therapeutic option for
      pseudobulbar affect in the ALS/MND spectrum.
differential_diagnoses:
- name: Myasthenia Gravis
  disease_term:
    preferred_term: myasthenia gravis
    term:
      id: MONDO:0009688
      label: myasthenia gravis
  description: >
    Autoimmune neuromuscular junction disorder that can present with bulbar weakness, but
    characteristically fatigable, fluctuating, and with ocular involvement (ptosis,
    diplopia); responsive to acetylcholinesterase inhibitors and immunotherapy.
  distinguishing_features:
  - Fatigable, fluctuating weakness rather than steadily progressive degeneration.
  - Acetylcholine receptor / MuSK antibodies and decremental response on repetitive nerve stimulation.
  - No tongue fasciculations or atrophy; no upper-motor-neuron (pseudobulbar) signs.
  evidence:
  - reference: PMID:41194820
    reference_title: "A Diagnostic Challenge in Progressive Limb Weakness: A Case of Myasthenia Gravis With Atypical Distal and Cranial Nerve Involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Myasthenia gravis (MG) is an autoimmune neuromuscular disorder commonly"
    explanation: >
      Myasthenia gravis is an autoimmune neuromuscular-junction disorder with fatigable
      weakness, distinguishing it from the degenerative bulbar palsy of PBP.
- name: Amyotrophic Lateral Sclerosis
  disease_term:
    preferred_term: amyotrophic lateral sclerosis
    term:
      id: MONDO:0004976
      label: amyotrophic lateral sclerosis
  description: >
    The broader motor neuron disease into which most PBP cases evolve; ALS adds prominent
    limb and respiratory (spinal) motor involvement beyond the bulbar region.
  distinguishing_features:
  - Generalized limb upper- and lower-motor-neuron involvement, not confined to bulbar region.
  - PBP is regarded as a bulbar-onset regional variant of the same disease process.
  evidence:
  - reference: PMID:40364643
    reference_title: "Latest progress and challenges in drug development for degenerative motor neuron diseases."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The main types include amyotrophic lateral sclerosis, progressive muscular atrophy, primary lateral sclerosis, and progressive bulbar palsy, the pathological processes of which are largely identical, with the main disparity lying in the location of the lesions"
    explanation: >
      ALS and progressive bulbar palsy are listed among the main motor neuron disease types
      with largely identical pathology, differing in lesion location.
- name: Brainstem Stroke
  disease_term:
    preferred_term: brain stem infarction
    term:
      id: MONDO:0006686
      label: brain stem infarction
  description: >
    Acute vascular brainstem lesion can produce bulbar weakness (dysarthria, dysphagia) but
    with sudden onset, additional crossed sensory/long-tract signs, and characteristic MRI
    findings, contrasting with the insidious, purely motor course of PBP.
  distinguishing_features:
  - Acute/sudden onset rather than insidious progression.
  - Associated long-tract and sensory signs; diffusion-restricted lesion on MRI.
references:
- reference: PMID:40364643
  title: "Latest progress and challenges in drug development for degenerative motor neuron diseases."
📚

References & Deep Research

References

1
PMID:40364643
Latest progress and challenges in drug development for degenerative motor neuron diseases.
No top-level findings curated for this source.